-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Alzamend Neuro, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
- Alzamend Neuro, Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was -$962K, a 72.7% increase year-over-year.
- Alzamend Neuro, Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$7.37M, a 52% increase year-over-year.
- Alzamend Neuro, Inc. annual Operating Income (Loss) for 2023 was -$9.94M, a 33.2% increase from 2022.
- Alzamend Neuro, Inc. annual Operating Income (Loss) for 2022 was -$14.9M, a 20.7% decline from 2021.
- Alzamend Neuro, Inc. annual Operating Income (Loss) for 2021 was -$12.3M, a 149% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)